CN101085185A - 白芍栀子饮料 - Google Patents
白芍栀子饮料 Download PDFInfo
- Publication number
- CN101085185A CN101085185A CN 200710069393 CN200710069393A CN101085185A CN 101085185 A CN101085185 A CN 101085185A CN 200710069393 CN200710069393 CN 200710069393 CN 200710069393 A CN200710069393 A CN 200710069393A CN 101085185 A CN101085185 A CN 101085185A
- Authority
- CN
- China
- Prior art keywords
- gram
- white sugar
- grams
- paeoniae alba
- radix paeoniae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title abstract description 5
- 240000001972 Gardenia jasminoides Species 0.000 title description 2
- 244000236658 Paeonia lactiflora Species 0.000 title description 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 title description 2
- 229930006000 Sucrose Natural products 0.000 claims abstract description 15
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000002657 fibrous material Substances 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 241001057584 Myrrha Species 0.000 claims description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 7
- 238000005202 decontamination Methods 0.000 claims description 6
- 230000003588 decontaminative effect Effects 0.000 claims description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims 2
- 238000000034 method Methods 0.000 abstract description 4
- 206010037660 Pyrexia Diseases 0.000 abstract description 3
- 235000005911 diet Nutrition 0.000 abstract description 3
- 244000170916 Paeonia officinalis Species 0.000 abstract 2
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 2
- 238000009835 boiling Methods 0.000 abstract 2
- 238000001914 filtration Methods 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000282461 Canis lupus Species 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241001644295 Fritillaria przewalskii Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 238000012856 packing Methods 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 230000003750 conditioning effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- MQBFFYQCZCKSBX-UHFFFAOYSA-N 5-hydroxy-6,7,8-trimethoxy-2-(3,4,5-trimethoxyphenyl)chromen-4-one Chemical compound COC1=C(OC)C(OC)=CC(C=2OC3=C(OC)C(OC)=C(OC)C(O)=C3C(=O)C=2)=C1 MQBFFYQCZCKSBX-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- IGGUPRCHHJZPBS-UHFFFAOYSA-N nonacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCC IGGUPRCHHJZPBS-UHFFFAOYSA-N 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical group O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 229930188400 Gardenin Natural products 0.000 description 1
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- VLCHQFXSBHIBRV-KNNWKXJLSA-N Mussaenosidic acid Natural products O=C(O)C=1[C@@H]2[C@H]([C@H](O[C@@H]3[C@@H](O)[C@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@](O)(C)CC2 VLCHQFXSBHIBRV-KNNWKXJLSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- YSIFYNVXJOGADM-KDYWOABDSA-N Shanzhiside Chemical compound O([C@H]1[C@H]2[C@@H](C(=CO1)C(O)=O)[C@H](O)C[C@@]2(O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YSIFYNVXJOGADM-KDYWOABDSA-N 0.000 description 1
- PVPIPGMAEAJMTH-UHFFFAOYSA-N Shanzhiside Natural products OCC1OC(OC2OC=C(C3C(O)CC(O)C23)C(=O)O)C(O)C(O)C1O PVPIPGMAEAJMTH-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种清热、解毒、祛淤的药膳饮品及其制备方法，主要由白芍、牡丹皮、栀子、川贝母、蒲公英、青皮、没药、枳壳、金银花、当归、茯苓等配方配比，以纤维性材料袋装，制药时将上述药物洗净，去杂质，放入铝锅内，加水中火烧沸，再用文火煎熬25分钟，过滤去渣，留汁液，加入白糖得到的产品，本发明有良好的清热解毒、祛淤消肿的作用，尤其是对治疗、调理肝癌诸症效果显著，除此之外，本发明还可以作为保健的常用饮品，价格低廉，制作简单，无毒副作用，饮用方便，口感好，有较好的经济和社会效益。
Description
技术领域
本发明涉及一种治疗、调理肝癌的药物组合及制备方法，尤其是清热解毒、祛淤消肿的保健药膳。
背景技术
肝癌的起病比较隐匿，早期肝癌一般没有任何症状，当患者出现明显的临床症状时，病情往往已属于中晚期。肝癌的首发症状以肝区疼痛最为常见，其次是上腹部包块、纳差、乏力、消瘦、原因不明发热、腹泻、腹痛、右肩酸痛等，若采用手术治疗，术后患者多因伤及气血而致全身乏力、四肢酸软、纳差自汗；肝癌晚期病人多处于全身衰竭状态，进食困难。
对肝癌的治疗至今仍然是人类末被攻克的大敌，现有技术中，西医一般采用手术、放疗、化疗等方法进行治疗，这种方法对人体的机体带来很大的副作用，且治疗效果有一定的局限性，治愈率较低；中医采用草药制剂，这种草药制剂中有许多成分含有不同程度的有毒物质，对患者肠、胃有一定的损害，治疗效果不够明显。
另一方面，干扰素疗法也有以下副作用：常见的如消化系统反应，有食欲不振、味觉异常、恶心、呕吐、泄泻、腹胀等，还可引起暂时的反应性精神分裂症，一般来说，副作用的程度与剂量大小相关，剂量越大，副作用也越明显。
综上所述，一般治疗上述症状的生物制剂在治疗效果上不能满足需要，更好地为患者减轻痛苦；也有少数药效比较好的配方及成剂，但成药的服用方式药效吸收差，达不到有效治疗的目的；再者治疗费用高，不易为众多患者所接受。
发明内容
本发明的目的是提供一种制作简单、制药成本低、服用方便、治疗效果明显且对人体无副作用、治疗及调理肝癌效果好的汤剂。
一种用于治疗调理肝癌症状及预防其相关并发症的汤剂，所提供的技术方案是：取白芍35-40克，牡丹皮、栀子、川贝母各15-20克，蒲公英、青皮、没药、枳壳、金银花各10-12克，当归25-30克，茯苓20-25克，白糖30-32克，以纤维性材料袋装，制药时将上述药物洗净，去杂质，放入铝锅内，加水中火烧沸，再用文火煎熬25分钟，过滤去渣，留汁液，加入白糖得到的产品。
为实现本发明所提供的制备方法包括以下步骤：
a、将原料洗净，去杂质，放入铝锅内；
b、加水500毫升，中火烧沸，再用文火煎熬25分钟；
c、过滤去渣，留汁液，加入白糖；
本发明的白芍栀子饮，色黄，性平味甘，具有清热、解毒、祛淤的功效。白芍是常用的传统中药，具有养血柔肝、缓中止痛、敛阴收汗的功效，主治胸腹胁肋疼痛，泻痢腹痛，自汗盗汗，阴虚发热，月经不调，崩漏，带下等；栀子气微，味淡微酸，含黄酮类栀子素、果胶、鞣质、藏红花素、藏红花酸、D-甘露醇、廿九烷、β-谷甾醇，另含多种具环臭蚁醛结构的甙：栀子甙、去羟栀子甙泊素-1-葡萄糖甙，格尼泊素-1-β-D-龙胆二糖甙及小量的山栀甙等，主要有(1)利胆作用；(2)镇静、降压作用；(3)抗微生物作用；(4)对机体肠管平滑肌有低浓度兴奋、高浓度抑制作用；当归为伞形科植物，味甘、性温，有补血活血，调经止痛，润肠通便的作用，用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡；金银花清热解毒，有退热、抗菌的作用；川贝母清热润肺、止咳化痰，可平喘、镇咳、降压、抗溃疡。
本发明与现有技术相比，它不用吃药、打针、打点滴等，也不用住院治疗，制作简单，且成本低廉，和白糖配方，降低了药味，口感更好，比西医常用的药物疗法使患者满意率提高了30％，治愈率达到20％，有效率在90％以上，未发现有任何毒副作用，尤其是对治疗调理肝癌诸症状效果显著。除此之外，本发明还可作为保健的常用饮品，具有清热解毒、利水消肿的功效，适合春夏季饮用，且价格低廉，无毒副作用，饮用方便，有较好的经济和社会效益。
具体实施方案
实际制药中，可将白芍35-40克，牡丹皮、栀子、川贝母各15-20克，蒲公英、青皮、没药、枳壳、金银花各10-12克，当归25-30克，茯苓20-25克，白糖30-32克，以纤维性材料袋装，制药时将上述药物洗净，去杂质，放入铝锅内，加水中火烧沸，再用文火煎熬25分钟，过滤去渣，留汁液，加入白糖得到的产品。
下面结合实施例对本发明的内容作进一步说明：
实施例一
配伍为：白芍35-40克，牡丹皮、栀子、川贝母各15-20克，蒲公英、青皮、没药、枳壳、金银花各10-12克，当归25-30克，茯苓20-25克，白糖30-32克。
制备方法：
a、将原料洗净，去杂质，放入铝锅内；
b、加水500毫升，中火烧沸，再用文火煎熬25分钟；
c、过滤去渣，留汁液，加入白糖；
实施例二
配伍为：白芍40克，牡丹皮、栀子、川贝母各20克，蒲公英、青皮、没药、枳壳、金银花各12克，当归30克，茯苓25克，白糖32克，其制备方法同实施例一。
实施例三
配伍为：白芍35克，牡丹皮、栀子、川贝母各15克，蒲公英、青皮、没药、枳壳、金银花各10克，当归25克，茯苓20克，白糖30克，其制备方法同实施例一。
综上所述，本发明的服用量可分为治疗和保健两种，对于患者来说可每日分早中晚3次餐前饮用，作为常人保健饮品服用时间不限，本发明无任何副作用，用药安全性能高，可每日1次饮用。
本发明治疗的理论根据是以清热解毒、祛淤消肿的纯中药作为原料，通过易吸收的汤剂方式给药，经临床试验表明，本发明的药膳有良好的清热、解毒、祛淤的作用，有效率在90％以上，为临床治疗肝癌等症状提供了有力的依据。
Claims (3)
1.一种白芍栀子饮，其特征在于由以下配方配比组成：白芍35-40克，牡丹皮、栀子、川贝母各15-20克，蒲公英、青皮、没药、枳壳、金银花各10-12克，当归25-30克，茯苓20-25克，白糖30-32克，以纤维性材料袋装，制药时将上述药物洗净，去杂质，放入铝锅内，加水中火烧沸，再用文火煎熬25分钟，过滤去渣，留汁液，加入白糖得到的产品。
2.根据权利要求1所述，本发明的制备方法是：
a、将原料洗净，去杂质，放入铝锅内；
b、加水500毫升，中火烧沸，再用文火煎熬25分钟；
c、过滤去渣，留汁液，加入白糖。
3.根据权利要求1所述，其特征在本发明由以下配方配比组成：白芍40克，牡丹皮、栀子、川贝母各20克，蒲公英、青皮、没药、枳壳、金银花各12克，当归30克，茯苓25克，白糖32克，其制备方法同权利要求2。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200710069393 CN101085185A (zh) | 2007-06-21 | 2007-06-21 | 白芍栀子饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200710069393 CN101085185A (zh) | 2007-06-21 | 2007-06-21 | 白芍栀子饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101085185A true CN101085185A (zh) | 2007-12-12 |
Family
ID=38936470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200710069393 Pending CN101085185A (zh) | 2007-06-21 | 2007-06-21 | 白芍栀子饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101085185A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102309047A (zh) * | 2010-07-06 | 2012-01-11 | 湖南敬和堂制药有限公司 | 一种清肝护肝的绿豆中药复方饮料的配方及制备工艺 |
| CN102860556A (zh) * | 2012-10-19 | 2013-01-09 | 丁耀辉 | 一种降火保健饮品及其制备方法 |
-
2007
- 2007-06-21 CN CN 200710069393 patent/CN101085185A/zh active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102309047A (zh) * | 2010-07-06 | 2012-01-11 | 湖南敬和堂制药有限公司 | 一种清肝护肝的绿豆中药复方饮料的配方及制备工艺 |
| CN102309047B (zh) * | 2010-07-06 | 2014-11-19 | 湖南敬和堂制药有限公司 | 一种清肝护肝的绿豆中药复方饮料的配方及制备工艺 |
| CN102860556A (zh) * | 2012-10-19 | 2013-01-09 | 丁耀辉 | 一种降火保健饮品及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103099959B (zh) | 一种治疗溃疡性结肠炎的中药制剂及其制备方法 | |
| CN100460008C (zh) | 治疗癌症的中药组合物 | |
| CN102742700B (zh) | 一种凉茶 | |
| CN102188614A (zh) | 胃溃疡胶囊药 | |
| CN103301267A (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
| CN108653434A (zh) | 一种治疗脾虚痰湿型多囊卵巢综合征的药物组合物 | |
| CN103330837B (zh) | 一种治疗绝经妇女骨质疏松症的中药组合物 | |
| CN105412424A (zh) | 一种含有艾叶的润肠通便的药物制剂及其制备方法 | |
| CN101085185A (zh) | 白芍栀子饮料 | |
| CN103550548B (zh) | 一种治疗便秘的中药组合物 | |
| CN104353043A (zh) | 一种治疗五更泻的中药组合物及其制备方法 | |
| CN105056170A (zh) | 一种中药组合物在制备治疗急性胃炎药物中的用途 | |
| CN102166295B (zh) | 一种治疗癌病的中药组合物 | |
| CN103071125B (zh) | 一种治疗子宫内膜异位症的中药组合物及其制备方法 | |
| CN102861292A (zh) | 一种治疗食管癌的药物及其制备方法 | |
| CN100571739C (zh) | 治疗心血管疾病的复方中药及其制备方法 | |
| CN101129997A (zh) | 郁金解表口服液 | |
| CN101642518A (zh) | 用于治疗痛经的膏药 | |
| CN1063074C (zh) | 一种治疗肿瘤的中药注射液及制造方法 | |
| CN105125693A (zh) | 一种治疗急性胃炎的中药组合物及其制备方法 | |
| CN105998448A (zh) | 提高免疫力的桑葚口服液制备方法及其口服液 | |
| CN106620140A (zh) | 一种治疗水牛腐蹄病的中药组合物 | |
| CN105169277A (zh) | 一种保肝利胆的栀子口服液及其制备方法 | |
| CN121695207A (zh) | 一种具有防治乳腺增生功效的中药组合物及其制备方法 | |
| CN1742988A (zh) | 治疗肝郁气滞型泌尿系结石的中草药汤剂及制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Wu Xiaoyang Document name: Notification of before Expiration of Request of Examination as to Substance |
|
| DD01 | Delivery of document by public notice |
Addressee: Wu Xiaoyang Document name: Notification that Application Deemed to be Withdrawn |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20071212 |